Personal CFO Solutions LLC Acquires 1,516 Shares of Zoetis Inc. (NYSE:ZTS)

Personal CFO Solutions LLC boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 21.5% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 8,552 shares of the company’s stock after buying an additional 1,516 shares during the period. Personal CFO Solutions LLC’s holdings in Zoetis were worth $1,393,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new stake in Zoetis during the third quarter valued at $31,000. First Personal Financial Services bought a new stake in Zoetis during the third quarter worth about $33,000. Capital Performance Advisors LLP bought a new stake in Zoetis during the third quarter worth about $33,000. Dunhill Financial LLC lifted its stake in Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after purchasing an additional 75 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC lifted its stake in Zoetis by 482.8% during the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company’s stock worth $28,000 after purchasing an additional 140 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Insider Activity at Zoetis

In related news, EVP Roxanne Lagano sold 326 shares of the business’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total transaction of $55,804.68. Following the transaction, the executive vice president now owns 16,107 shares in the company, valued at $2,757,196.26. The trade was a 1.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.16% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ZTS. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Leerink Partners began coverage on Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price target for the company. Piper Sandler lifted their price target on Zoetis from $200.00 to $205.00 and gave the stock an “overweight” rating in a research note on Thursday, February 27th. StockNews.com raised Zoetis from a “hold” rating to a “buy” rating in a research note on Friday. Finally, Stifel Nicolaus dropped their price target on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $215.90.

Zoetis Stock Up 1.8 %

ZTS opened at $170.34 on Friday. The company has a market cap of $76.28 billion, a P/E ratio of 31.14, a P/E/G ratio of 2.78 and a beta of 0.94. The business’s 50-day moving average price is $166.72 and its 200-day moving average price is $176.78. The company has a current ratio of 1.75, a quick ratio of 1.08 and a debt-to-equity ratio of 1.09. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.33.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The company had revenue of $2.32 billion for the quarter, compared to the consensus estimate of $2.30 billion. On average, equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 21st. This represents a $2.00 dividend on an annualized basis and a yield of 1.17%. Zoetis’s dividend payout ratio is presently 36.56%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.